Part A and Part B Drug Codes
Led countless manufacturers in the application submission for Part B HCPCS Coding and Pass-Through Status and supported manufacturers in advocacy efforts to ensure optimal code award. For Part A, led manufacturers through the New Technology Add-on Payment (NTAP) application submission process, including data to support submissions. ADVI Strategic Analytics and Value Economics (SAVE) practice performed the cost criterion analysis for the NTAP applications as well as provided analytics support to clients to help understand payment implication of NTAP expiration. For Part B, used claims data and manufacturer pricing information to analyze a product based on the pass-through cost criterion and estimate potential reimbursement with pass-through status.